Day One Biopharmaceuticals (DAWN)
(Delayed Data from NSDQ)
$14.23 USD
+0.82 (6.11%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $14.25 +0.02 (0.14%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.22 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 92.54% |
ABR | 1.30 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.68 |
Next Year | -2.12 |
EPS (TTM) | -1.95 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 36.57M | 17.42M | 62.19M | 121.63M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 83.29M | 21.00M | 107.49M | 154.60M |
Low Estimate | 9.75M | 11.46M | 29.40M | 76.98M |
Year ago Sales | 0.00M | 0.00M | NA | 62.19M |
Year over Year Growth Est. | NA | NA | NA | 95.58% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.22 | -0.73 | -1.68 | -2.12 |
# of Estimates | 7 | 6 | 8 | 8 |
Most Recent Consensus | -0.73 | -0.73 | -2.23 | -2.03 |
High Estimate | 0.30 | -0.42 | -0.79 | -0.75 |
Low Estimate | -0.79 | -1.08 | -2.37 | -4.29 |
Year ago EPS | -0.54 | -0.64 | -2.37 | -1.68 |
Year over Year Growth Est. | 59.26% | -14.06% | 29.11% | -26.27% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 4 | 1 | 8 | 4 |
Up Last 60 Days | 4 | 1 | 8 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 5 | 0 | 4 |
Down Last 60 Days | 2 | 5 | 0 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.22 | -0.73 | -1.68 | -2.12 |
7 Days Ago | -0.22 | -0.73 | -1.68 | -2.12 |
30 Days Ago | -0.69 | -0.65 | -2.69 | -2.22 |
60 Days Ago | -0.69 | -0.65 | -2.69 | -2.22 |
90 Days Ago | -0.69 | -0.66 | -2.83 | -2.23 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.22 | -0.73 | -1.68 | -2.12 |
Zacks Consensus Estimate | -0.22 | -0.73 | -1.68 | -2.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -0.72 | -0.64 | -0.54 | NA |
Estimate | -0.67 | -0.67 | -0.57 | -0.60 | NA |
Difference | 0.62 | -0.05 | -0.07 | 0.06 | 0.14 |
Surprise | 92.54% | -7.46% | -12.28% | 10.00% | 20.70% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more